Aequus Pharmaceuticals Inc Working Capital to Net Assets Ratio
Aequus Pharmaceuticals Inc working capital to net assets ratio. Aequus Pharmaceuticals Inc (AQS) has a Working Capital to Net Assets ratio of 100.0% as of September 2025. Working capital of CA$-6.89 Million (current assets of CA$196.16K minus current liabilities of CA$7.09 Million) is measured against net assets of CA$-6.89 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Aequus Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Aequus Pharmaceuticals Inc (2013–2024)
Working capital to net assets ratio of Aequus Pharmaceuticals Inc from 2013 to 2024. This chart shows how Aequus Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting working capital of CA$-6.89 Million against net assets of CA$-6.89 Million CAD. See AQS days of operational coverage to measure how many days the company can operate on defensive assets alone.
Aequus Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2013–2024)
Aequus Pharmaceuticals Inc working capital to net assets ratio by year from 2013 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Aequus Pharmaceuticals Inc from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Aequus Pharmaceuticals Inc total assets.
| Year | WC/NA Ratio | Working Capital (CAD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 100.9% | CA$-6.51 Million | CA$-6.45 Million | CA$282.00K | CA$6.80 Million | ▼ -0.6 pp |
| 2023 | 101.6% | CA$-4.36 Million | CA$-4.29 Million | CA$435.61K | CA$4.80 Million | ▼ -5.3 pp |
| 2022 | 106.9% | CA$-1.48 Million | CA$-1.38 Million | CA$902.69K | CA$2.38 Million | ▲ +43.4 pp |
| 2021 | 63.5% | CA$1.14 Million | CA$1.79 Million | CA$3.59 Million | CA$2.46 Million | ▼ -351.9 pp |
| 2020 | 415.4% | CA$2.38 Million | CA$573.95K | CA$2.77 Million | CA$384.32K | ▲ +487.4 pp |
| 2019 | -72.0% | CA$631.69K | CA$-877.09K | CA$1.11 Million | CA$476.05K | ▼ -126.7 pp |
| 2018 | 54.7% | CA$920.17K | CA$1.68 Million | CA$1.24 Million | CA$314.90K | ▼ -3.8 pp |
| 2017 | 58.5% | CA$1.35 Million | CA$2.31 Million | CA$1.71 Million | CA$366.84K | ▲ +53.8 pp |
| 2016 | 4.7% | CA$59.14K | CA$1.27 Million | CA$803.55K | CA$744.41K | ▼ -14.0 pp |
| 2015 | 18.7% | CA$239.86K | CA$1.28 Million | CA$1.38 Million | CA$1.15 Million | ▼ -81.1 pp |
| 2014 | 99.8% | CA$2.92 Million | CA$2.92 Million | CA$3.66 Million | CA$744.51K | ▲ +2.2 pp |
| 2013 | 97.6% | CA$273.85K | CA$280.60K | CA$330.59K | CA$56.74K | — |